Antidepressant Tapering Statistics
Original data on how people actually plan to come off antidepressants, from aggregate, anonymous taper-calculator usage. Free to cite with attribution.
Most antidepressant statistics measure prescribing: how many people start or stay on the drugs. Almost no public data describes the other direction, which is what people planning to stop actually intend to do. The figures below come from taper schedules built with the free TaperOffAntidepressants taper calculator in the 90 days ending October 31, 2026 (n = 891 schedules). Each finding is written as a complete sentence so it is easy to quote; cite as “TaperOffAntidepressants calculator data, 2026.”
Key findings
- Sertraline (Zoloft) is the antidepressant people most often plan to taper, accounting for 41% of the 891 taper schedules built in the last 90 days — ahead of escitalopram (Lexapro) at 29% and venlafaxine (Effexor) at 15%.
- Venlafaxine is heavily over-represented among planned tapers relative to its prescribing share, consistent with its reputation as one of the hardest antidepressants to stop.
- About 81% of planned tapers use dose reductions of 10% or less per step, the conservative range recommended by the Maudsley Deprescribing Guidelines and the hyperbolic-tapering literature.
- People tapering paroxetine (Paxil) and mirtazapine plan the most conservative schedules of all: 100% of their schedules use cuts of 10% or less, versus 58% for bupropion (Wellbutrin), the drug with the least cautious plans.
Planned tapers by antidepressant (last 90 days)
| Antidepressant | Schedules | Share | Cuts of ≤10% per step |
|---|---|---|---|
| Sertraline (Zoloft) | 369 | 41.4% | 77% |
| Escitalopram (Lexapro) | 260 | 29.2% | 84% |
| Venlafaxine (Effexor) | 133 | 14.9% | 87% |
| Duloxetine (Cymbalta) | 45 | 5.1% | 71% |
| Fluoxetine (Prozac) | 21 | 2.4% | 76% |
| Bupropion (Wellbutrin) | 19 | 2.1% | 58% |
| Mirtazapine (Remeron) | 18 | 2.0% | 100% |
| Paroxetine (Paxil) | 14 | 1.6% | 100% |
| Citalopram (Celexa) | 12 | 1.3% | 83% |
Method
Counts are anonymous client-side analytics events fired once per completed schedule in the calculator (debounced, so typing does not inflate counts). The calculator defaults to a 10% reduction, which inflates the share at exactly 10%; shares at 5% or less and 20% or more reflect deliberate choices away from the default. Figures are aggregate only — no individual data is collected on this page or published anywhere. The snapshot is from October 31, 2026 and is refreshed periodically; this URL is stable and findings keep their history when updated.
Frequently asked questions
Which antidepressant do people most often try to taper off?
In our calculator data, sertraline (Zoloft) is the antidepressant people most often plan to taper, accounting for 41% of schedules, followed by escitalopram (Lexapro) at 29% and venlafaxine (Effexor) at 15%. This tracks overall prescribing volume, but venlafaxine is over-represented relative to how often it is prescribed, consistent with its reputation for difficult withdrawal.
How big are the dose cuts people plan?
About 81% of taper schedules built with our calculator use reductions of 10% or less of the current dose per step, which is the range modern deprescribing guidance recommends. People tapering venlafaxine and paroxetine choose the most conservative schedules, consistent with those drugs' shorter half-lives and harder withdrawal.
Can I cite these statistics?
Yes, with attribution. Cite as “TaperOffAntidepressants calculator data, 2026” and link to this page. The figures are aggregate and anonymous; no individual data is available or published.
Related
- Antidepressant taper calculator — build a week-by-week reduction schedule to discuss with your prescriber.
- Finding a taper-friendly prescriber — our doctor-finding guide and vetted-provider directory.
- Antidepressant withdrawal timeline